Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.73 |
| ▸ | XDH | P47989 | 1/20 | 0.55 |
| ▸ | SELP | P16109 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | SELE | P16581 | 1/20 | 0.39 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.38 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL421130 | 0.95 | HSP90AA1 (0.72) | HSP90AA1XDHSELPPOLBCTDSP1 | |
| SCHEMBL419313 | 0.85 | HSP90AA1 (0.71) | HSP90AA1XDHKDM4EGLACYP3A4 | |
| Catalposide SCHEMBL419598 | 0.84 | HSP90AA1 (1.00) | HSP90AA1XDHPOLBCTDSP1KDM4E | |
| SCHEMBL29733539 | 0.82 | HSP90AA1 (0.70) | HSP90AA1XDHKDM4EGLACYP3A4 | |
| SCHEMBL19004036 | 0.82 | HSP90AA1 (0.70) | HSP90AA1XDHKDM4EGLACYP3A4 | |
| SCHEMBL31345813 | 0.82 | HSP90AA1 (0.70) | HSP90AA1XDHPOLBCTDSP1KDM4E | |
| SCHEMBL29426089 | 0.81 | HSP90AA1 (0.73) | HSP90AA1XDHKDM4EGLACYP3A4 | |
| SCHEMBL29425944 | 0.81 | HSP90AA1 (0.70) | HSP90AA1XDHKDM4EGLACYP3A4 | |
| Verproside SCHEMBL31619362 | 0.81 | HSP90AA1 (0.83) | HSP90AA1XDHPOLBCTDSP1KDM4E | |
| Verproside SCHEMBL2449966 | 0.81 | HSP90AA1 (0.83) | HSP90AA1XDHPOLBCTDSP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409766-A1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N-Zyme BioTec GmbH (DE) | 2018-12-05 | — | — | EP | disclosed |
| US-20150086655-A1 | Morinda Citrifolia Juice Formulations Comprising Iridoids | WEST BRETT JUSTIN (US) | 2015-03-26 | — | — | US | disclosed |
| US-8790727-B2 | Morinda citrifolia and iridoid based formulations | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-8679550-B2 | Morinda citrifolia juice formulations comprising iridoids | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120328720-A1 | Iridoid Based Formulations | MORINDA, INC. | 2012-12-27 | — | — | US | disclosed |
| US-20120021079-A1 | Garcinia Mangostana L. and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2012-01-26 | — | — | US | disclosed |
| US-20110217394-A1 | Iridoid Based Formulations | WEST BRETT JUSTIN | 2011-09-08 | — | — | US | disclosed |
| WO-2011106432-A2 | MORINDA CITRIFOLIA AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106417-A2 | GARCINIA MANGOSTANA L. AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110206786-A1 | Acai and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2011-08-25 | — | — | US | disclosed |
| US-20110206787-A1 | Morinda Citrifolia and Iridoid Based Formulations | MORINDA, INC. | 2011-08-25 | — | — | US | disclosed |